MedTrace Logo

Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence

NCT06939400 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-04-22

No results posted yet for this study

Summary

GBM patients receiving PDT treatment (50 cases，surgery combined with photodynamic therapy) and traditional treatment (50 cases，traditional surgery) in our hospital and partner hospitals were collected. The prognosis was analyzed by comparing with the control group from multiple perspectives such as image evaluation, imaging effect, Karnofsky score, median survival time and survival rate.

Conditions

  • Glioblastoma Multiforme (GBM)

Interventions

PROCEDURE

Photodynamic therapy (PDT)

GBM patients recevied surgical combination photodynamic therapy

PROCEDURE

GBM patients recevied traditional treatment options

GBM patients recevied traditional treatment options (including surgery combined with radiotherapy and chemotherapy)

Sponsors & Collaborators

  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • Zhejiang Provincial People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06939400 on ClinicalTrials.gov